Page last updated: 2024-08-21

tetramethylpyrazine and Osteoporosis

tetramethylpyrazine has been researched along with Osteoporosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, B; Han, YH; Hu, YQ; Huang, Q; Jie, Q; Liu, BH; Lu, WG; Luo, ZJ; Shi, J; Wang, L; Yang, L; Zhang, HY; Zhao, ZJ	1

Other Studies

1 other study(ies) available for tetramethylpyrazine and Osteoporosis

Article	Year
Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats. Stem cells and development, 2017, 03-15, Volume: 26, Issue:6 Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Bone and Bones; Dexamethasone; Glucocorticoids; Mesenchymal Stem Cells; Organ Size; Osteogenesis; Osteoporosis; Protective Agents; Pyrazines; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases	2017

Article

Year

Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.

Stem cells and development, 2017, 03-15, Volume: 26, Issue:6

Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Bone and Bones; Dexamethasone; Glucocorticoids; Mesenchymal Stem Cells; Organ Size; Osteogenesis; Osteoporosis; Protective Agents; Pyrazines; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases

2017